Plain-English translation of NCT07522944 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether an artificial intelligence-guided relaxation program can help people undergoing kidney dialysis feel less anxious and more able to cope with their treatment. If you join, you'll either receive personalized relaxation sessions—including deep breathing, guided imagery, and mindfulness exercises—delivered through a digital platform during your regular dialysis appointments, or continue with your standard care. The researchers will measure changes in your anxiety, mood, coping skills, and relaxation levels before and after the intervention.
Many people receiving long-term kidney dialysis experience significant anxiety and stress, which can affect both their mental health and how well they manage their treatment. This study aims to see whether AI-guided relaxation tools can offer an accessible, personalized way to help patients cope better during their dialysis sessions.
You likely qualify if…
You likely don't qualify if…
If you are randomly selected for the treatment group, you will receive personalized relaxation sessions guided by artificial intelligence during your regular dialysis appointments—these include exercises like deep breathing, progressive muscle relaxation, and guided imagery delivered through headphones on a digital platform. The control group will receive their standard dialysis care without the AI relaxation program. All participants will complete questionnaires and interviews before and after the study period to measure changes in anxiety, mood, coping, and how relaxed they feel.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Egypt